Multiplex Assays Market Forecast 2025–2034: Where Businesses Should Invest Next

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Is The Projected Market Size Of The Multiplex Assays Market By 2029?

The multiplex assays market has shown substantial expansion in recent years. Its size is projected to increase from $3.67 billion in 2024 to $3.88 billion in 2025, reflecting a compound annual growth rate (CAGR) of 6.0%. The significant growth observed in the preceding period can be ascribed to elements such as elevated healthcare expenditure, the development of emerging markets, swift technological progress, and a quickening in the growth of the aging demographic.

The multiplex assays market is set for robust expansion over the next few years, with projections indicating a rise to $5.33 billion by 2029, achieving a compound annual growth rate (CAGR) of 8.2%. This anticipated growth is largely driven by increased funding, government initiatives supporting genetic and microbiological research, an expanding aging population, the growing prevalence of chronic diseases, and a swift increase in various bacterial and viral epidemics, which also constitute the major trends for the forecast period.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5775&type=smp

What Are The Key Drivers Of Growth In The Multiplex Assays Market?

The escalating prevalence of chronic diseases is fueling the expansion of the global multiplex assay market. Multiplex assay is extensively employed in clinical trials to evaluate disease efficacy and identify antibodies against specific illnesses. For instance, in September 2023, a report from the World Health Organization, a Switzerland-based United Nations health organization, highlighted that chronic diseases, also known as non-communicable diseases (NCDs), account for 74% of global deaths, totaling 41 million fatalities. Therefore, the increasing incidence of chronic diseases is expected to propel the global multiplex assay market.

Which Key Segments Fueling The Multiplex Assays Market?

The multiplex assaysmarket covered in this report is segmented –

1) By Type: Protein-Based Multiplex Assays, Nucleic Acid-Based Multiplex Assays, Other Types

2) By Identification Technology: Flow Cytometry, Multiplex Real-Time PCR, Other Identification Technologies

3) By Detection Technology: Enzyme-Linked Immunosorbent Assay (ELISA), Luminescence, Fluorescence, Other Detection Technologies

4) By Application: Research And Development, Clinical Diagnostics

5) By End User: Pharmaceutical And Biotechnology Companies, Hospitals And Research Institutes, Reference Laboratories, Other End-Users

Subsegments:

1) By Protein-Based Multiplex Assays: ELISA (Enzyme-Linked Immunosorbent Assay); Luminex xMAP Technology; Western Blotting; Immunohistochemistry; Mass Spectrometry-Based Assays

2) By Nucleic Acid-Based Multiplex Assays: PCR (Polymerase Chain Reaction); qPCR (Quantitative PCR); NGS (Next-Generation Sequencing); Microarray Analysis; RT-PCR (Reverse Transcription PCR)

3) By Other Types: Cell-Based Multiplex Assays; Bioanalytical Assays; Imaging-Based Assays; Surface Plasmon Resonance (SPR) Assays

Which Market Trends Are Creating New Opportunities In The Multiplex Assays Industry?

Market entities are introducing innovative diagnostic tests based on multiplex assays to reinforce their competitive position. For example, in May 2022, QuantuMDx Group Limited, a UK-based developer of transformative point-of-care diagnostics, unveiled its latest respiratory panel test, the Q-POC SARS-CoV-2, Flu A/B, and RSV (respiratory syncytial virus) Assay. This Q-POCTM SARS (severe acute respiratory syndrome)-CoV-2, Flu A/B, and RSV Assay operates as a multiplex panel, equipped to detect SARS-CoV-2, Flu A, Flu B, and RSV (respiratory syncytial virus) precisely at the point of need.

Which Key Players Are Driving Competition In The Multiplex Assays Market?

Major companies operating in the multiplex assays market include Seegene Inc, DiaSorin SpA, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, Abcam Plc, PerkinElmer Inc, Hologic Corporation, Meso Scale Diagnostics, Merck KGaA, Roche Diagnostics India Pvt Ltd, bioMérieux India, Becton Dickinson Private Limited, Danaher Corporation, Johnson & Johnson, Simens Healthcare, Beckman Coulter Inc. India, Ortho Clinical Diagnostics, Sysmex Corporation, Siemens Healthineers Ukraine, TestLine Clinical Diagnostics s.r.o., Cepheid, F. Hoffmann-La Roche Ltd., Hologic, Bayer AG, Cantel Medical Corporation, Meridian Bioscience, Faizyme Laboratories, Alere Inc., Bangs Laboratories Inc, The Merck Group, Takara Bio Inc, Qiagen, Spherotech Inc, Geneaid Biotech Ltd, Rockland Immunochemicals Inc, GenScript Biotech Corporation

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/multiplex-assays-global-market-report

How Is Multiplex Assays Market Demand Varying Across Different Regions?

North America was the largest region in the multiplex assays market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the multiplex assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Multiplex Assays Market Report:

https://www.thebusinessresearchcompany.com/customise?id=5775&type=smp

Browse Through More Reports Similar to the Global Multiplex Assays Market 2025, By The Business Research Company

Neurology Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neurology-devices-global-market-report

Neurodegenerative Disorder Therapeutic Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neurodegenerative-disorder-therapeutic-global-market-report

Neurophysiology Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neurophysiology-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795